Charles Kummeth
Overview
Charles Kummeth received an average of $12M in total compensation, including $1M in salary, at Bio-Techne from 2017 to 2022.
Source: SEC filings on September 14, 2022 and September 9, 2019.
Related executives
We found eight more executives who work or worked at Bio-Techne.
James Hippel
Bio-Techne
Chief Financial Officer
David Eansor
Bio-Techne
Former President, Protein Sciences
Brenda Furlow
Bio-Techne
General Counsel
Kim Kelderman
Bio-Techne
President, Diagnostics and Genomics
William Geist
Bio-Techne
President, Protein Sciences
Marcel Veronneau
Bio-Techne
Vice President Hematology Operations
Gregory Melsen
Bio-Techne
Chief Financial Officer
Thomas Oland
Bio-Techne